Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol

Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM .
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM .

Works citing "Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol"

Lisa M Hess, David M Kern, Gebra Cuyun Carter, Liya Wang, Katherine Winfree, Zhanglin Lin Cui, Angelina Sontag, Ana B Oton

JMIR Res Protoc 2017 (Oct 11); 6(10):e195

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.7750):

(note that this is only a small subset of citations)

Deverka PA, Douglas MP, Phillips KA. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions. Value in Health 2020;23(5):540
CrossRef
Hammond ER, Tummala R, Berglind A, Syed F, Wang X, Desta B, Nab H. Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature. BMJ Open 2020;10(9):e036563
CrossRef
Grabner M, Molife C, Wang L, Winfree KB, Cui ZL, Cuyun Carter G, Hess LM. Data Integration to Improve Real-world Health Outcomes Research for Non–Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration. JMIR Cancer 2021;7(2):e23161
CrossRef
Chouaïd C, Grumberg V, Batisse A, Corre R, Giaj Levra M, Gaudin A, Prodel M, Lortet-Tieulent J, Assié J, Cotté F. Machine Learning–Based Analysis of Treatment Sequences Typology in Advanced Non–Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab. JCO Clinical Cancer Informatics 2022;(6)
CrossRef